Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Coronavirus Vaccine Market Size Growth Rate by Type: 2018 VS 2023 VS 2033
1.2.2 Coronavirus Inactivated Vaccine
1.2.3 Live Attenuated Coronavirus Vaccine
1.2.4 Coronavirus Vaccine Based On S Protein
1.3 Market by Application
1.3.1 Global Coronavirus Vaccine Market Growth by Application: 2018 VS 2023 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Coronavirus Vaccine Market Perspective (2018-2033)
2.2 Coronavirus Vaccine Growth Trends by Region
2.2.1 Global Coronavirus Vaccine Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 Coronavirus Vaccine Historic Market Size by Region (2018-2023)
2.2.3 Coronavirus Vaccine Forecasted Market Size by Region (2024-2033)
2.3 Coronavirus Vaccine Market Dynamics
2.3.1 Coronavirus Vaccine Industry Trends
2.3.2 Coronavirus Vaccine Market Drivers
2.3.3 Coronavirus Vaccine Market Challenges
2.3.4 Coronavirus Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Coronavirus Vaccine Players by Revenue
3.1.1 Global Top Coronavirus Vaccine Players by Revenue (2018-2023)
3.1.2 Global Coronavirus Vaccine Revenue Market Share by Players (2018-2023)
3.2 Global Coronavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Coronavirus Vaccine Revenue
3.4 Global Coronavirus Vaccine Market Concentration Ratio
3.4.1 Global Coronavirus Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Coronavirus Vaccine Revenue in 2023
3.5 Coronavirus Vaccine Key Players Head office and Area Served
3.6 Key Players Coronavirus Vaccine Product Solution and Service
3.7 Date of Enter into Coronavirus Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Coronavirus Vaccine Breakdown Data by Type
4.1 Global Coronavirus Vaccine Historic Market Size by Type (2018-2023)
4.2 Global Coronavirus Vaccine Forecasted Market Size by Type (2024-2033)
5 Coronavirus Vaccine Breakdown Data by Application
5.1 Global Coronavirus Vaccine Historic Market Size by Application (2018-2023)
5.2 Global Coronavirus Vaccine Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Coronavirus Vaccine Market Size (2018-2033)
6.2 North America Coronavirus Vaccine Market Growth Rate by Country: 2018 VS 2023 VS 2033
6.3 North America Coronavirus Vaccine Market Size by Country (2018-2023)
6.4 North America Coronavirus Vaccine Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Coronavirus Vaccine Market Size (2018-2033)
7.2 Europe Coronavirus Vaccine Market Growth Rate by Country: 2018 VS 2023 VS 2033
7.3 Europe Coronavirus Vaccine Market Size by Country (2018-2023)
7.4 Europe Coronavirus Vaccine Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Coronavirus Vaccine Market Size (2018-2033)
8.2 Asia-Pacific Coronavirus Vaccine Market Growth Rate by Region: 2018 VS 2023 VS 2033
8.3 Asia-Pacific Coronavirus Vaccine Market Size by Region (2018-2023)
8.4 Asia-Pacific Coronavirus Vaccine Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Coronavirus Vaccine Market Size (2018-2033)
9.2 Latin America Coronavirus Vaccine Market Growth Rate by Country: 2018 VS 2023 VS 2033
9.3 Latin America Coronavirus Vaccine Market Size by Country (2018-2023)
9.4 Latin America Coronavirus Vaccine Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Coronavirus Vaccine Market Size (2018-2033)
10.2 Middle East & Africa Coronavirus Vaccine Market Growth Rate by Country: 2018 VS 2023 VS 2033
10.3 Middle East & Africa Coronavirus Vaccine Market Size by Country (2018-2023)
10.4 Middle East & Africa Coronavirus Vaccine Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Іnоvіо Рhаrmасеutісаlѕ
11.1.1 Іnоvіо Рhаrmасеutісаlѕ Company Detail
11.1.2 Іnоvіо Рhаrmасеutісаlѕ Business Overview
11.1.3 Іnоvіо Рhаrmасеutісаlѕ Coronavirus Vaccine Introduction
11.1.4 Іnоvіо Рhаrmасеutісаlѕ Revenue in Coronavirus Vaccine Business (2018-2023)
11.1.5 Іnоvіо Рhаrmасеutісаlѕ Recent Development
11.2 Моdеrnа
11.2.1 Моdеrnа Company Detail
11.2.2 Моdеrnа Business Overview
11.2.3 Моdеrnа Coronavirus Vaccine Introduction
11.2.4 Моdеrnа Revenue in Coronavirus Vaccine Business (2018-2023)
11.2.5 Моdеrnа Recent Development
11.3 Nоvаvах
11.3.1 Nоvаvах Company Detail
11.3.2 Nоvаvах Business Overview
11.3.3 Nоvаvах Coronavirus Vaccine Introduction
11.3.4 Nоvаvах Revenue in Coronavirus Vaccine Business (2018-2023)
11.3.5 Nоvаvах Recent Development
11.4 Рrоtеіn Роtеntіаl
11.4.1 Рrоtеіn Роtеntіаl Company Detail
11.4.2 Рrоtеіn Роtеntіаl Business Overview
11.4.3 Рrоtеіn Роtеntіаl Coronavirus Vaccine Introduction
11.4.4 Рrоtеіn Роtеntіаl Revenue in Coronavirus Vaccine Business (2018-2023)
11.4.5 Рrоtеіn Роtеntіаl Recent Development
11.5 АlрhаVах
11.5.1 АlрhаVах Company Detail
11.5.2 АlрhаVах Business Overview
11.5.3 АlрhаVах Coronavirus Vaccine Introduction
11.5.4 АlрhаVах Revenue in Coronavirus Vaccine Business (2018-2023)
11.5.5 АlрhаVах Recent Development
11.6 Ѕуnаіrgеn РLС
11.6.1 Ѕуnаіrgеn РLС Company Detail
11.6.2 Ѕуnаіrgеn РLС Business Overview
11.6.3 Ѕуnаіrgеn РLС Coronavirus Vaccine Introduction
11.6.4 Ѕуnаіrgеn РLС Revenue in Coronavirus Vaccine Business (2018-2023)
11.6.5 Ѕуnаіrgеn РLС Recent Development
11.7 NаnоVіrісіdеѕ
11.7.1 NаnоVіrісіdеѕ Company Detail
11.7.2 NаnоVіrісіdеѕ Business Overview
11.7.3 NаnоVіrісіdеѕ Coronavirus Vaccine Introduction
11.7.4 NаnоVіrісіdеѕ Revenue in Coronavirus Vaccine Business (2018-2023)
11.7.5 NаnоVіrісіdеѕ Recent Development
11.8 GGеnеСurе
11.8.1 GGеnеСurе Company Detail
11.8.2 GGеnеСurе Business Overview
11.8.3 GGеnеСurе Coronavirus Vaccine Introduction
11.8.4 GGеnеСurе Revenue in Coronavirus Vaccine Business (2018-2023)
11.8.5 GGеnеСurе Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Coronavirus Vaccine Market Size Growth Rate by Type (US$ Million): 2018 VS 2023 VS 2033
Table 2. Key Players of Coronavirus Inactivated Vaccine
Table 3. Key Players of Live Attenuated Coronavirus Vaccine
Table 4. Key Players of Coronavirus Vaccine Based On S Protein
Table 5. Global Coronavirus Vaccine Market Size Growth by Application (US$ Million): 2018 VS 2023 VS 2033
Table 6. Global Coronavirus Vaccine Market Size by Region (US$ Million): 2018 VS 2023 VS 2033
Table 7. Global Coronavirus Vaccine Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Coronavirus Vaccine Market Share by Region (2018-2023)
Table 9. Global Coronavirus Vaccine Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Coronavirus Vaccine Market Share by Region (2024-2033)
Table 11. Coronavirus Vaccine Market Trends
Table 12. Coronavirus Vaccine Market Drivers
Table 13. Coronavirus Vaccine Market Challenges
Table 14. Coronavirus Vaccine Market Restraints
Table 15. Global Coronavirus Vaccine Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Coronavirus Vaccine Market Share by Players (2018-2023)
Table 17. Global Top Coronavirus Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronavirus Vaccine as of 2023)
Table 18. Ranking of Global Top Coronavirus Vaccine Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Coronavirus Vaccine Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Coronavirus Vaccine Product Solution and Service
Table 22. Date of Enter into Coronavirus Vaccine Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Coronavirus Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Coronavirus Vaccine Revenue Market Share by Type (2018-2023)
Table 26. Global Coronavirus Vaccine Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Coronavirus Vaccine Revenue Market Share by Type (2024-2033)
Table 28. Global Coronavirus Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Coronavirus Vaccine Revenue Market Share by Application (2018-2023)
Table 30. Global Coronavirus Vaccine Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Coronavirus Vaccine Revenue Market Share by Application (2024-2033)
Table 32. North America Coronavirus Vaccine Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 33. North America Coronavirus Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Coronavirus Vaccine Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Coronavirus Vaccine Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 36. Europe Coronavirus Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Coronavirus Vaccine Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Coronavirus Vaccine Market Size Growth Rate by Region (US$ Million): 2018 VS 2023 VS 2033
Table 39. Asia-Pacific Coronavirus Vaccine Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Coronavirus Vaccine Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Coronavirus Vaccine Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 42. Latin America Coronavirus Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Coronavirus Vaccine Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Coronavirus Vaccine Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 45. Middle East & Africa Coronavirus Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Coronavirus Vaccine Market Size by Country (2024-2033) & (US$ Million)
Table 47. Іnоvіо Рhаrmасеutісаlѕ Company Detail
Table 48. Іnоvіо Рhаrmасеutісаlѕ Business Overview
Table 49. Іnоvіо Рhаrmасеutісаlѕ Coronavirus Vaccine Product
Table 50. Іnоvіо Рhаrmасеutісаlѕ Revenue in Coronavirus Vaccine Business (2018-2023) & (US$ Million)
Table 51. Іnоvіо Рhаrmасеutісаlѕ Recent Development
Table 52. Моdеrnа Company Detail
Table 53. Моdеrnа Business Overview
Table 54. Моdеrnа Coronavirus Vaccine Product
Table 55. Моdеrnа Revenue in Coronavirus Vaccine Business (2018-2023) & (US$ Million)
Table 56. Моdеrnа Recent Development
Table 57. Nоvаvах Company Detail
Table 58. Nоvаvах Business Overview
Table 59. Nоvаvах Coronavirus Vaccine Product
Table 60. Nоvаvах Revenue in Coronavirus Vaccine Business (2018-2023) & (US$ Million)
Table 61. Nоvаvах Recent Development
Table 62. Рrоtеіn Роtеntіаl Company Detail
Table 63. Рrоtеіn Роtеntіаl Business Overview
Table 64. Рrоtеіn Роtеntіаl Coronavirus Vaccine Product
Table 65. Рrоtеіn Роtеntіаl Revenue in Coronavirus Vaccine Business (2018-2023) & (US$ Million)
Table 66. Рrоtеіn Роtеntіаl Recent Development
Table 67. АlрhаVах Company Detail
Table 68. АlрhаVах Business Overview
Table 69. АlрhаVах Coronavirus Vaccine Product
Table 70. АlрhаVах Revenue in Coronavirus Vaccine Business (2018-2023) & (US$ Million)
Table 71. АlрhаVах Recent Development
Table 72. Ѕуnаіrgеn РLС Company Detail
Table 73. Ѕуnаіrgеn РLС Business Overview
Table 74. Ѕуnаіrgеn РLС Coronavirus Vaccine Product
Table 75. Ѕуnаіrgеn РLС Revenue in Coronavirus Vaccine Business (2018-2023) & (US$ Million)
Table 76. Ѕуnаіrgеn РLС Recent Development
Table 77. NаnоVіrісіdеѕ Company Detail
Table 78. NаnоVіrісіdеѕ Business Overview
Table 79. NаnоVіrісіdеѕ Coronavirus Vaccine Product
Table 80. NаnоVіrісіdеѕ Revenue in Coronavirus Vaccine Business (2018-2023) & (US$ Million)
Table 81. NаnоVіrісіdеѕ Recent Development
Table 82. GGеnеСurе Company Detail
Table 83. GGеnеСurе Business Overview
Table 84. GGеnеСurе Coronavirus Vaccine Product
Table 85. GGеnеСurе Revenue in Coronavirus Vaccine Business (2018-2023) & (US$ Million)
Table 86. GGеnеСurе Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Coronavirus Vaccine Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Coronavirus Vaccine Market Share by Type: 2023 VS 2033
Figure 3. Coronavirus Inactivated Vaccine Features
Figure 4. Live Attenuated Coronavirus Vaccine Features
Figure 5. Coronavirus Vaccine Based On S Protein Features
Figure 6. Global Coronavirus Vaccine Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Coronavirus Vaccine Market Share by Application: 2023 VS 2033
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Research Institute Case Studies
Figure 11. Other Case Studies
Figure 12. Coronavirus Vaccine Report Years Considered
Figure 13. Global Coronavirus Vaccine Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Coronavirus Vaccine Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 15. Global Coronavirus Vaccine Market Share by Region: 2023 VS 2033
Figure 16. Global Coronavirus Vaccine Market Share by Players in 2023
Figure 17. Global Top Coronavirus Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronavirus Vaccine as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Coronavirus Vaccine Revenue in 2023
Figure 19. North America Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Coronavirus Vaccine Market Share by Country (2018-2033)
Figure 21. United States Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Coronavirus Vaccine Market Share by Country (2018-2033)
Figure 25. Germany Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Coronavirus Vaccine Market Share by Region (2018-2033)
Figure 33. China Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Coronavirus Vaccine Market Share by Country (2018-2033)
Figure 41. Mexico Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Coronavirus Vaccine Market Share by Country (2018-2033)
Figure 45. Turkey Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Coronavirus Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Іnоvіо Рhаrmасеutісаlѕ Revenue Growth Rate in Coronavirus Vaccine Business (2018-2023)
Figure 48. Моdеrnа Revenue Growth Rate in Coronavirus Vaccine Business (2018-2023)
Figure 49. Nоvаvах Revenue Growth Rate in Coronavirus Vaccine Business (2018-2023)
Figure 50. Рrоtеіn Роtеntіаl Revenue Growth Rate in Coronavirus Vaccine Business (2018-2023)
Figure 51. АlрhаVах Revenue Growth Rate in Coronavirus Vaccine Business (2018-2023)
Figure 52. Ѕуnаіrgеn РLС Revenue Growth Rate in Coronavirus Vaccine Business (2018-2023)
Figure 53. NаnоVіrісіdеѕ Revenue Growth Rate in Coronavirus Vaccine Business (2018-2023)
Figure 54. GGеnеСurе Revenue Growth Rate in Coronavirus Vaccine Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed